Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.
Open Access
- 1 September 1982
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 14 (3) , 399-404
- https://doi.org/10.1111/j.1365-2125.1982.tb01998.x
Abstract
1 The fluctuations in protein binding of sodium valproate during one dosing interval were studied in five patients stabilized on valproate and taking concurrent anticonvulsant therapy. 2 The patients took their usual morning dose of valproate (400-800 mg) and serial blood samples were collected by venepuncture at 0, 1, 2, 3, 4, and 6 h post-dose. 3 Free valproate was separated from protein bound drug by plasma ultrafiltration and the ultrafiltrate and total plasma valproate concentrations were measured by a gas chromatographic method. 4 The maximum and minimum concentrations in the ultrafiltrates occurred at the same times as in the plasma. However, the percentage fluctuation was always greater in the ultrafiltrates (range 192-412%) compared with the plasma (range 153-374%) due to the concentration-dependent nature of valproate protein binding. 5 If free valproate levels are to be monitored, knowledge of sampling time and dosage history is important for interpretation of the results.This publication has 27 references indexed in Scilit:
- Protein binding Of valproic acid in uremic patientsNeurology, 1980
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Therapeutic Monitoring of Valproic AcidTherapeutic Drug Monitoring, 1980
- Monitoring of Free Valproic Acid Levels?Therapeutic Drug Monitoring, 1980
- Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled StudyEpilepsia, 1979
- Plasma protein binding interaction between phenytoin and valproic acid in vitro.British Journal of Clinical Pharmacology, 1978
- Distribution of valproate across the interface between blood and cerebrospinal fluidNeuropharmacology, 1978
- Valproic acid in epilepsy: Clinical and pharmacological effectsAnnals of Neurology, 1978
- Valproic Acid: Reversibly Acting Drug?Epilepsia, 1976
- Sodium Valproate in Treatment of EpilepsyBMJ, 1974